Synthesis of heparin oligosaccharides and their interaction with eosinophil-derived neurotoxin (Q38329756)

2 September 2017

Synthesis of heparin oligosaccharides and their interaction with eosinophil-derived neurotoxin (English)

1 reference

2 September 2017

1 reference

1 reference

Shang-Cheng Hung

1

1 reference

2 September 2017

Xin-An Lu

2

1 reference

2 September 2017

Jinq-Chyi Lee

3

1 reference

2 September 2017

Margaret Dah-Tsyr Chang

4

1 reference

2 September 2017

Shun-lung Fang

5

1 reference

2 September 2017

Tan-chi Fan

6

1 reference

2 September 2017

Medel Manuel L Zulueta

7

1 reference

2 September 2017

Yong-Qing Zhong

8

1 reference

2 September 2017

6 December 2011

1 reference

Organic and Biomolecular Chemistry

2 September 2017

1 reference

2 September 2017

10

1 reference

2 September 2017

4

1 reference

2 September 2017

760-772

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

2 September 2017

1 reference

Eosinophil granule proteins and their role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

A heparan sulfate-facilitated and raft-dependent macropinocytosis of eosinophil cationic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Characterization of molecular interactions between eosinophil cationic protein and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Eosinophil-derived neurotoxin / RNase 2: connecting the past, the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Ribonuclease is partly responsible for the HIV-1 inhibitory effect activated by HLA alloantigen recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Heparin and heparan sulfate: structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Order out of chaos: assembly of ligand binding sites in heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Heparan sulphate proteoglycans: the sweet side of development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

The structure of glycosaminoglycans and their interactions with proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Lessons learned from the contamination of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Heparin-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: structure and activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Heparan sulphate proteoglycans fine-tune mammalian physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Interactions between heparan sulfate and proteins: the concept of specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Cell surface heparan sulfate and its roles in assisting viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Roles of heparan-sulphate glycosaminoglycans in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

The sweet and sour of cancer: glycans as novel therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Heparan sulfate: a complex polymer charged with biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Design of biologically active heparan sulfate and heparin using an enzyme-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Synthetic heparin derivatives as new anticoagulant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Synthesis of heparin oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Synthesis of a 3-deoxy-L-iduronic acid containing heparin pentasaccharide to probe the conformation of the antithrombin III binding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

The activation of fibroblast growth factors by heparin: synthesis, structure, and biological activity of heparin-like oligosaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Recent chemical and enzymatic approaches to the synthesis of glycosaminoglycan oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Modular synthesis of heparin oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Use of Cerny Epoxides for the Accelerated Synthesis of Glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

From D-glucose to biologically potent L-hexose derivatives: synthesis of alpha-L-iduronidase fluorogenic detector and the disaccharide moieties of bleomycin A2 and heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

A modular strategy toward the synthesis of heparin-like oligosaccharides using monomeric building blocks in a sequential glycosylation strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Synthesis of 48 disaccharide building blocks for the assembly of a heparin and heparan sulfate oligosaccharide library

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Microarrays of synthetic heparin oligosaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Toward synthesis of the regular sequence of heparin: synthesis of two tetrasaccharide precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Anomeric reactivity-based one-pot synthesis of heparin-like oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Preactivation-based, one-pot combinatorial synthesis of heparin-like hexasaccharides for the analysis of heparin-protein interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Divergent heparin oligosaccharide synthesis with preinstalled sulfate esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Regioselective one-pot protection of carbohydrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Regioselective one-pot protection of glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Regioselective one-pot protection of D-glucosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Cu(OTf)2 as an efficient and dual-purpose catalyst in the regioselective reductive ring opening of benzylidene acetals

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

Synthesis of iduronic acid building blocks for the modular assembly of glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

1,6-anhydro-beta-l-hexopyranoses as potent synthons in the synthesis of the disaccharide units of bleomycin A(2) and heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

An efficient synthesis of L-idose and L-iduronic acid thioglycosides and their use for the synthesis of heparin oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

New principles for glycoside-bond formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

General approach to the synthesis of persubstituted hydrophilic and amphiphilic beta-cyclodextrin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

First Synthesis of Heparan Sulfate Tetrasaccharides Containing both N-Acetylated and N-Unsubstituted Glucosamine-Search for Putative 10E4 Epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC1OB06415K

21 January 2018

Identifiers

DOI

10.1039/C1OB06415K

1 reference

2 September 2017

1 reference